This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WASHINGTON — Legislation to restrict U.S. drugmakers from using key Chinese contract manufacturers was dealt a major blow when senators left it out of a must-pass defense budget bill this weekend. The BIOSECURE Act would prohibit pharmaceutical and biotechnology companies from using services or equipment from Chinese “companies of concern,” including WuXi AppTec and WuXi Biologics, in work that is contracted or funded by the U.S. federal government.
The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceutical companies.
SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a panel discussion among sickle cell experts Saturday at STAT@ASH , which took place during the American Society of Hematology’s annual meeting. They said patients were despondent over how suddenly the drug was pulled from the market in September because there had been no clear indication of problems in advance of the announcement.
In November 2024, the pharma and healthcare industry reported 95 deals worth $14.8 billion, compared to the last 12-month (November 2023 to October 2024) average of 102 deals worth $16.8 billion. Hoffmann-La Roche, to acquire Poseida Therapeutics, a clinical-stage allogeneic cell therapy and genetic medicine company for an equity value of $1.5 billion; Ampersand Capital Partners and GHO Capital Partners, to acquire Avid Bioservices, a biologics contract development and manufacturing organisation
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
In this episode, Ill discuss tranexamic acid for controlling iatrogenic bleeding during flexible bronchoscopy. Subscribe on iTunes , Android , or Stitcher While pharmacists are not typically present when a bronchoscopy takes place, medications are involved both to help the patient tolerate the procedure and to address issues that come up as a result of the procedure.
Fosfomycin is an antibiotic (discovered in 1969) that has been making a resurgence in popularity in the last few years due to its activity against both gram-positive and gram-negative bacteria. Currently, it is a treatment option for women with uncomplicated urinary tract infections with the benefit being that it can be given in a single […] The post Top 5 Fosfomycin Clinical Pearls appeared first on Med Ed 101.
52
52
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Fosfomycin is an antibiotic (discovered in 1969) that has been making a resurgence in popularity in the last few years due to its activity against both gram-positive and gram-negative bacteria. Currently, it is a treatment option for women with uncomplicated urinary tract infections with the benefit being that it can be given in a single […] The post Top 5 Fosfomycin Clinical Pearls appeared first on Med Ed 101.
By identifying patients at high risk for progressing to severe disease and counseling them on their treatment options, pharmacists empower patients to make informed decisions about their treatment.
The phase 3 AMPLIFY trial demonstrates that fixed-duration regimens of acalabrutinib and venetoclax, with or without obinutuzumab, significantly improve progression-free survival and deliver manageable safety profiles compared to chemoimmunotherapy in treatment-naive chronic lymphocytic leukemia (CLL).
SAN DIEGO — Bone marrow transplants can be lifesaving for patients with acute myeloid leukemia, but new research reveals how socioeconomic factors create barriers to treatment and higher death rates for people living in disadvantaged communities. A scientific team led by researchers at Fred Hutchinson Cancer Center tracked AML patients across academic and community treatment centers.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
In hospital and critical care settings, pharmacists can play a significant role in educating other health care providers about treatment options, proper dosing, and more.
(This roundup of news from the ASH 2024 conference first appeared in STAT’s “ASH in 30” newsletter. To get future editions, sign up here.) When in San Diego, eat tacos. Amazing. Adam, Jonathan, Meghana, and Angus are back for your Sunday ASH rundown. And thanks to everyone who packed the room last night for our STAT @ ASH event.
Rejoicing is a Christian duty and privilege. In fact, it is to be a perpetual ornament of the character of every believer in Christ Jesus. “Rejoice in the Lord always”, says Paul to the Philippians in chapter 4:4 of that epistle, “and again I say, rejoice!” And there is much for us to be joyful […] The post The Sighing Christian appeared first on The Honest Apothecary.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmacists can leverage continuous glucose monitoring data to personalize diabetes management, overcome clinical inertia, and improve glycemic control for patients.
The cause of an outbreak of illness in a remote part of the Democratic Republic of the Congo that has garnered substantial international attention is still not known. But a statement released Sunday by the World Health Organization both sheds some light on why the source of the illness hasn’t yet been identified and what the illness — or illnesses — might be.
Shirley D'Sa, MD, highlights the long-term efficacy and tolerability of zanubrutinib in patients with Waldenstrm macroglobulinemia, as seen in the long-term extension of ASPEN.
President-elect Donald Trump suggested in a television interview on Sunday that he shares some of the concerns voiced by Robert F. Kennedy Jr., his choice to be secretary of health and human services, about the safety of some common childhood vaccines. The comments, made on NBC’s Meet the Press , represent an increased sign of support for RFK Jr. taking action on that topic if he is confirmed by the Senate.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The AQUILA study demonstrates that early treatment with daratumumab significantly delays progression to symptomatic multiple myeloma, improves survival outcomes, and offers a well-tolerated alternative to traditional observation.
Both statins and newer non-statin medications are important in combination to effectively lower atherogenic lipid levels and reduce cardiovascular risk.
26
26
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
310 
Let's personalize your content